{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T13:58:01Z","timestamp":1771855081448,"version":"3.50.1"},"reference-count":41,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"14","license":[{"start":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T00:00:00Z","timestamp":1640822400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2021,12,30]]},"DOI":"10.1167\/tvst.10.14.37","type":"journal-article","created":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T16:34:34Z","timestamp":1640882074000},"page":"37","source":"Crossref","is-referenced-by-count":6,"title":["Topical Ketotifen Fumarate Inhibits Choroidal Mast Cell Degranulation and Loss of Retinal Pigment Epithelial Cells in Rat Model for Geographic Atrophy"],"prefix":"10.1167","volume":"10","author":[{"given":"Tomohiro","family":"Nizawa","sequence":"first","affiliation":[{"name":"Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imran A.","family":"Bhutto","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anupama","family":"Tiwari","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhonda R.","family":"Grebe","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse","family":"Alt","sequence":"additional","affiliation":[{"name":"Brain Science Institute, Johns Hopkins Drug Discovery, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana","family":"Rais","sequence":"additional","affiliation":[{"name":"Brain Science Institute, Johns Hopkins Drug Discovery, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malia M.","family":"Edwards","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard A.","family":"Lutty","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"27","reference":[{"issue":"5","key":"bib1","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.ophtha.2013.11.023","article-title":"Geographic atrophy: clinical features and potential therapeutic approaches","volume":"121","author":"Holz","year":"2014","journal-title":"Ophthalmology"},{"issue":"4","key":"bib2","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1001\/archopht.1941.00870100042005","article-title":"Prevalence of age-related macular degeneration in the United States","volume":"122","author":"Friedman","year":"2004","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"bib3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.mam.2012.06.003","article-title":"Animal models of age related macular degeneration","volume":"33","author":"Pennesi","year":"2012","journal-title":"Mol Aspects Med"},{"issue":"Pt 2","key":"bib4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/eye.1997.49","article-title":"The distribution of immune cells in the uveal tract of the normal eye","volume":"11","author":"McMenamin","year":"1997","journal-title":"Eye (Lond)"},{"key":"bib5","first-page":"620","article-title":"Mast Cell: A Multi-Functional Master Cell","volume":"6","author":"Krystel-Whittemore","year":"2015","journal-title":"Front Immunol"},{"issue":"1","key":"bib6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bbadis.2010.12.014","article-title":"Mast cells and inflammation","volume":"1822","author":"Theoharides","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"bib7","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/nri3690","article-title":"Mast cell secretory granules: armed for battle","volume":"14","author":"Wernersson","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"bib8","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/ana.2004.59.issue-7","article-title":"Mast cell tryptase: a review of its physiology and clinical significance","volume":"59","author":"Payne","year":"2004","journal-title":"Anaesthesia"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ejphar.2015.04.050","article-title":"The impact of mast cells on cardiovascular diseases","volume":"778","author":"Kritikou","year":"2016","journal-title":"Eur J Pharmacol"},{"issue":"Suppl 1","key":"bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/vop.12035","article-title":"Mast cells are present in the choroid of the normal eye in most vertebrate classes","volume":"16","author":"McMenamin","year":"2013","journal-title":"Vet Ophthalmol"},{"issue":"3","key":"bib11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/bjo.78.3.211","article-title":"Distribution and characterisation of rat choroidal mast cells","volume":"78","author":"Steptoe","year":"1994","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"bib12","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1136\/bjophthalmol-2015-308290","article-title":"Increased choroidal mast cells and their degranulation in age-related macular degeneration","volume":"100","author":"Bhutto","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"bib13","first-page":"16","article-title":"Role of C3a and C5a in the activation of mast cells","volume":"14","author":"Erdei","year":"1997","journal-title":"Exp Clin Immunogenet"},{"issue":"6","key":"bib14","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1158\/0008-5472.CAN-13-2729","article-title":"Alarmin IL-33 acts as an immunoadjuvant to enhance antigen-specific tumor immunity","volume":"74","author":"Villarreal","year":"2014","journal-title":"Cancer Res"},{"issue":"1","key":"bib15","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/S0006-291X(02)03009-7","article-title":"The canine mast cell activation via CRP","volume":"301","author":"Fujimoto","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"bib16","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/j.1476-5381.2010.00905.x","article-title":"Advanced glycation end products (AGEs) activate mast cells","volume":"161","author":"Sick","year":"2010","journal-title":"Br J Pharmacol"},{"issue":"7","key":"bib17","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1073\/pnas.0408835103","article-title":"Drusen complement components C3a and C5a promote choroidal neovascularization","volume":"103","author":"Nozaki","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"bib18","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1136\/bjo.2010.199216","article-title":"C-reactive protein and complement factor H in aged human eyes and eyes with age-related macular degeneration","volume":"95","author":"Bhutto","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"bib19","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.exer.2005.10.005","article-title":"The expression of advanced glycation end product receptors in RPE cells associated with basal deposits in human maculas","volume":"82","author":"Yamada","year":"2006","journal-title":"Exp Eye Res"},{"issue":"13","key":"bib20","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.1167\/iovs.17-22989","article-title":"Mast Cell-Derived Tryptase in Geographic Atrophy","volume":"58","author":"McLeod","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"bib21","doi-asserted-by":"publisher","first-page":"10117","DOI":"10.1096\/fsb2.v34.8","article-title":"A role for mast cells in geographic atrophy","volume":"34","author":"Ogura","year":"2020","journal-title":"FASEB J"},{"issue":"1","key":"bib22","first-page":"CD001384","article-title":"Ketotifen alone or as additional medication for long-term control of asthma and wheeze in children","volume":"2004","author":"Schwarzer","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"bib23","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/joim.1991.229.issue-5","article-title":"A case of systemic mastocytosis; therapeutic efficacy of ketotifen","volume":"229","author":"Povoa","year":"1991","journal-title":"J Intern Med"},{"issue":"10","key":"bib24","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1136\/bjo.87.10.1206","article-title":"Australian Ketotifen Study G. Efficacy and safety of ketotifen eye drops in the treatment of seasonal allergic conjunctivitis","volume":"87","author":"Kidd","year":"2003","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"bib25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.5582\/ddt.2016.01019","article-title":"Generic selection criteria for safety and patient benefit [V]: Comparing the pharmaceutical properties and patient usability of original and generic nasal spray containing ketotifen fumarate","volume":"10","author":"Wada","year":"2016","journal-title":"Drug Discov Ther"},{"issue":"5","key":"bib26","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/alr.2015.5.issue-5","article-title":"Comparing the effects of ketotifen fumarate eye drops and ketotifen oral pills on symptom severity and quality of life in patients with allergic rhinitis: a double-blind randomized clinical trial","volume":"5","author":"Akhavan","year":"2015","journal-title":"Int Forum Allergy Rhinol"},{"issue":"2","key":"bib27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/all.1979.34.issue-2","article-title":"The protective effect of a new agent, ketotifen syrup, in the treatment of childhood asthma","volume":"34","author":"Osterballe","year":"1979","journal-title":"Allergy"},{"issue":"6","key":"bib28","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.anai.2013.10.003","article-title":"Ketotifen in the management of chronic urticaria: resurrection of an old drug","volume":"111","author":"Sokol","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"Del Amo","year":"2017","journal-title":"Prog Retin Eye Res"},{"issue":"7","key":"bib30","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1056\/NEJMra1714562","article-title":"Aspiration Pneumonia","volume":"380","author":"Mandell","year":"2019","journal-title":"N Engl J Med"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.biomaterials.2017.02.016","article-title":"Subconjunctival injectable dendrimer-dexamethasone gel for the treatment of corneal inflammation","volume":"125","author":"Soiberman","year":"2017","journal-title":"Biomaterials"},{"issue":"4","key":"bib32","doi-asserted-by":"publisher","first-page":"AMD143","DOI":"10.1167\/iovs.18-24245","article-title":"An Acute Injury Model for the Phenotypic Characteristics of Geographic Atrophy","volume":"59","author":"Bhutto","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"bib33","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/j.ajpath.2015.04.002","article-title":"Choroidal mast cells in retinal pathology: a potential target for intervention","volume":"185","author":"Bousquet","year":"2015","journal-title":"Am J Pathol"},{"issue":"1","key":"bib34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1089\/108076803762718132","article-title":"In vitro inhibition of human conjunctival mast-cell degranulation by ketotifen","volume":"19","author":"Schoch","year":"2003","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"bib35","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2165\/00003495-199040030-00006","article-title":"Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders","volume":"40","author":"Grant","year":"1990","journal-title":"Drugs"},{"issue":"1","key":"bib36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000438605","article-title":"Anti-Allergic Drugs Tranilast and Ketotifen Dose-Dependently Exert Mast Cell-Stabilizing Properties","volume":"38","author":"Baba","year":"2016","journal-title":"Cell Physiol Biochem"},{"issue":"14","key":"bib37","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.addr.2005.09.004","article-title":"Topical and systemic drug delivery to the posterior segments","volume":"57","author":"Hughes","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"bib38","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/pharmaceutics12030269","article-title":"Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations","volume":"12","author":"Varela-Fernandez","year":"2020","journal-title":"Pharmaceutics"},{"issue":"3","key":"bib39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1167\/tvst.4.3.11","article-title":"Topical Ocular Drug Delivery to the Back of the Eye by Mucus-Penetrating Particles","volume":"4","author":"Schopf","year":"2015","journal-title":"Transl Vis Sci Technol"},{"issue":"6","key":"bib40","doi-asserted-by":"publisher","first-page":"e00545","DOI":"10.1002\/prp2.v7.6","article-title":"Species differences in ocular pharmacokinetics and pharmacological activities of regorafenib and pazopanib eye-drops among rats, rabbits and monkeys","volume":"7","author":"Horita","year":"2019","journal-title":"Pharmacol Res Perspect"},{"issue":"4","key":"bib41","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/BF02848691","article-title":"Ocular tolerability and safety of ketotifen fumarate ophthalmic solution","volume":"19","author":"Abelson","year":"2002","journal-title":"Adv Ther"}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2778209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T16:34:41Z","timestamp":1640882081000},"score":1,"resource":{"primary":{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2778209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,30]]},"references-count":41,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.10.14.37","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,30]]}}}